1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow NDV-HXP-S IM high dose: new trials by email Literature Review of NDV-HXP-S IM high dose trials Research Report on NDV-HXP-S IM high dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose - SARS-CoV-2 | Phase 1 | Completed | Sean Liu | 35 | 2022-02-09 | 2025-04-17 |
COVID-19 (1)
Sean Liu (1)
United States (1)